Cargando…
Identifying cancer origin using circulating tumor cells
Circulating tumor cells (CTCs) have become an established clinical evaluation biomarker. CTC count provides a good correlation with the prognosis of cancer patients, but has only been used with known cancer patients, and has been unable to predict the origin of the CTCs. This study demonstrates the...
Autores principales: | Lu, Si-Hong, Tsai, Wen-Sy, Chang, Ying-Hsu, Chou, Teh-Ying, Pang, See-Tong, Lin, Po-Hung, Tsai, Chun-Ming, Chang, Ying-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910938/ https://www.ncbi.nlm.nih.gov/pubmed/26828696 http://dx.doi.org/10.1080/15384047.2016.1141839 |
Ejemplares similares
-
Early Detection and Dynamic Changes of Circulating Tumor Cells in Transgenic NeuN Transgenic (NTTg) Mice with Spontaneous Breast Tumor Development
por: Tsai, Wen-Sy, et al.
Publicado: (2021) -
Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016) -
Polycarboxybetaine-Based Hydrogels for the Capture and Release of Circulating Tumor Cells
por: Chien, Hsiu-Wen, et al.
Publicado: (2022) -
Patients with Epididymo-Orchitis and Meteorological Impact in Taiwan: A Nationwide Population-Based Study
por: Liu, Jui-Ming, et al.
Publicado: (2017) -
Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients
por: Tsai, Wen-Sy, et al.
Publicado: (2016)